Home The Word Brain My Amedeo FAQ Privacy About   

2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.

  Prostate Cancer

  Free Subscription

Articles published in Am J Pathol

Retrieve available abstracts of 8 articles:
HTML format

Single Articles

    December 2023
  1. CULIG Z, Puhr M
    Androgen receptor interacting proteins in prostate cancer development and therapy resistance.
    Am J Pathol. 2023 Dec 15:S0002-9440(23)00461.
    PubMed     Abstract available

    June 2023
  2. ZHANG Y, Li W, Guo S, Wu Z, et al
    FBXO22 mediates the NGF/TRKA signaling pathway in bone metastases in prostate cancer.
    Am J Pathol. 2023 Jun 8:S0002-9440(23)00204-3. doi: 10.1016/j.ajpath.2023.
    PubMed     Abstract available

  3. HANDLE F, Puhr M, Gruber M, Andolfi C, et al
    The oncogenic protein kinase/ATPase RIOK1 is up-regulated via the MYC/E2F transcription factor axis in prostate cancer.
    Am J Pathol. 2023 Jun 8:S0002-9440(23)00205-5. doi: 10.1016/j.ajpath.2023.
    PubMed     Abstract available

    February 2023
  4. ROY A, Prasad S, Chen Y, Chao Y, et al
    Protein kinase D2 and 3 promote prostate cancer cell bone metastasis by positively regulating Runx2 in a MEK/ERK1/2-dependent manner.
    Am J Pathol. 2023 Feb 3:S0002-9440(23)00036-6. doi: 10.1016/j.ajpath.2023.
    PubMed     Abstract available

    January 2023
  5. YU YP, Liu S, Ren BG, Nelson J, et al
    Fusion Gene Detection in Prostate Cancer Samples Enhances the Prediction of Prostate Cancer Clinical Outcomes from Radical Prostatectomy through Machine Learning in a Multi-institutional Analysis.
    Am J Pathol. 2023 Jan 18:S0002-9440(23)00029.
    PubMed     Abstract available

    October 2022
  6. LOW JY, Ko M, Hanratty B, Patel RA, et al
    Genomic Characterization of Prostatic Basal Cell Carcinoma.
    Am J Pathol. 2022 Oct 26. pii: S0002-9440(22)00320.
    PubMed     Abstract available

    June 2022
  7. MURESAN XM, Slabakova E, Prochazkova J, Drapela S, et al
    Toll-like receptor 3 (TLR3) overexpression induces invasion of prostate cancer cells, whereas its activation triggers apoptosis.
    Am J Pathol. 2022 Jun 21. pii: S0002-9440(22)00174.
    PubMed     Abstract available

    February 2022
  8. OFFERMANN A, Joerg V, Becker F, Roesch MC, et al
    Inhibition of CDK8/CDK19 suppresses its pro-oncogenic effects in prostate cancer.
    Am J Pathol. 2022 Feb 15. pii: S0002-9440(22)00047.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Prostate Cancer is free of charge.